Global Hemoglobin A1c Testing Devices Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Hemoglobin A1c Testing Devices Market Research Report 2024
Testing the levels of glycated hemoglobin provides an assurance to the healthcare practitioner about the patient’s blood glucose level. This test can be used for diagnosis and monitoring of hemoglobin A1c levels in diabetic patients.
According to MRAResearch’s new survey, global Hemoglobin A1c Testing Devices market is projected to reach US$ 3000.4 million in 2033, increasing from US$ 1652.6 million in 2022, with the CAGR of 8.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hemoglobin A1c Testing Devices market research.
Key manufacturers engaged in the Hemoglobin A1c Testing Devices industry include Abbott, ARKRAY, Bio-Rad, PTS Diagnostics, Beckman Coulter, EKF Diagnostics, Roche, Menarini Group and Sebia, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Hemoglobin A1c Testing Devices were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Hemoglobin A1c Testing Devices market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Hemoglobin A1c Testing Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abbott
ARKRAY
Bio-Rad
PTS Diagnostics
Beckman Coulter
EKF Diagnostics
Roche
Menarini Group
Sebia
Siemens Healthcare
Tosoh
Trinity Biotech
Segment by Type
Ion-Exchange HPLC
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Laboratory Testing
Point-of-Care (POC) Testing
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Hemoglobin A1c Testing Devices report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to MRAResearch’s new survey, global Hemoglobin A1c Testing Devices market is projected to reach US$ 3000.4 million in 2033, increasing from US$ 1652.6 million in 2022, with the CAGR of 8.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hemoglobin A1c Testing Devices market research.
Key manufacturers engaged in the Hemoglobin A1c Testing Devices industry include Abbott, ARKRAY, Bio-Rad, PTS Diagnostics, Beckman Coulter, EKF Diagnostics, Roche, Menarini Group and Sebia, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Hemoglobin A1c Testing Devices were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Hemoglobin A1c Testing Devices market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Hemoglobin A1c Testing Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
ARKRAY
Bio-Rad
PTS Diagnostics
Beckman Coulter
EKF Diagnostics
Roche
Menarini Group
Sebia
Siemens Healthcare
Tosoh
Trinity Biotech
Segment by Type
Ion-Exchange HPLC
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Segment by Application
Laboratory Testing
Point-of-Care (POC) Testing
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Hemoglobin A1c Testing Devices report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source